176 related articles for article (PubMed ID: 36578804)
1. Research Progress of Population Pharmacokinetic of Metformin.
Wang X; Tang J; Shen C; Wang X; Hu H; Xie H
Biomed Res Int; 2022; 2022():4071111. PubMed ID: 36578804
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.
Duong JK; Kumar SS; Kirkpatrick CM; Greenup LC; Arora M; Lee TC; Timmins P; Graham GG; Furlong TJ; Greenfield JR; Williams KM; Day RO
Clin Pharmacokinet; 2013 May; 52(5):373-84. PubMed ID: 23475568
[TBL] [Abstract][Full Text] [Related]
3. A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function.
Duong JK; Kroonen MYAM; Kumar SS; Heerspink HL; Kirkpatrick CM; Graham GG; Williams KM; Day RO
Eur J Clin Pharmacol; 2017 Aug; 73(8):981-990. PubMed ID: 28451709
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetic Analysis of Valsartan in Healthy Chinese Subjects.
Yang H; Gao R; Ji X; Wang Z; Qiu W
Clin Pharmacol Drug Dev; 2023 Mar; 12(3):249-256. PubMed ID: 36285517
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.
Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X
J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic models of anti-PD-1 mAbs in patients with multiple tumor types: A systematic review.
Shang J; Huang L; Huang J; Ren X; Liu Y; Feng Y
Front Immunol; 2022; 13():871372. PubMed ID: 35983041
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetic Models of Venetoclax in Hematologic Malignancies: A Systematic Review.
Zhao Y; Guo N; Zhu Y; Shang J; Chen J; Luo X; Liu Y; Zhang X; Huang L
Drug Des Devel Ther; 2024; 18():1771-1784. PubMed ID: 38828021
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus.
Bardin C; Nobecourt E; Larger E; Chast F; Treluyer JM; Urien S
Eur J Clin Pharmacol; 2012 Jun; 68(6):961-8. PubMed ID: 22274405
[TBL] [Abstract][Full Text] [Related]
9. Population PK/PD analysis of metformin using the signal transduction model.
Chae JW; Baek IH; Lee BY; Cho SK; Kwon KI
Br J Clin Pharmacol; 2012 Nov; 74(5):815-23. PubMed ID: 22380769
[TBL] [Abstract][Full Text] [Related]
10. Application of a Pharmacokinetic Model of Metformin Clearance in a Population with Acute Myeloid Leukemia.
Ceacareanu AC; Brown GW; Moussa HA; Wintrob ZAP
J Res Pharm Pract; 2018; 7(1):41-45. PubMed ID: 29755998
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic analysis of dutogliptin, a selective dipeptidyl peptidase-4 inhibitor.
Marier JF; Mouksassi MS; Gosselin NH; Li J
Clin Pharmacol Drug Dev; 2014 Jul; 3(4):297-304. PubMed ID: 27128836
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of cyclosporine A in Japanese renal transplant patients: comprehensive analysis in a single center.
Okada A; Ushigome H; Kanamori M; Morikochi A; Kasai H; Kosaka T; Kokuhu T; Nishimura A; Shibata N; Fukushima K; Yoshimura N; Sugioka N
Eur J Clin Pharmacol; 2017 Sep; 73(9):1111-1119. PubMed ID: 28620753
[TBL] [Abstract][Full Text] [Related]
13. [The Current State and Future Prospects of Population Pharmacokinetic Research in Post-marketing Clinical Studies in Japan].
Watanabe-Uchida M; Watanabe T; Narukawa M
Yakugaku Zasshi; 2019; 139(10):1297-1303. PubMed ID: 31582616
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method.
Liu X; Ju G; Yang W; Chen L; Xu N; He Q; Zhu X; Ouyang D
Drug Des Devel Ther; 2023; 17():2955-2967. PubMed ID: 37789969
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients.
Chen B; Shi HQ; Liu XX; Zhang WX; Lu JQ; Xu BM; Chen H
J Clin Pharm Ther; 2017 Dec; 42(6):679-688. PubMed ID: 28833329
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetic Analysis of Tiropramide in Healthy Korean Subjects.
Jeong SH; Jang JH; Cho HY; Lee YB
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32325672
[TBL] [Abstract][Full Text] [Related]
17. Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects.
Yoon H; Cho HY; Yoo HD; Kim SM; Lee YB
AAPS J; 2013 Apr; 15(2):571-80. PubMed ID: 23417334
[TBL] [Abstract][Full Text] [Related]
18. NONMEM population pharmacokinetic studies of cytosine arabinoside after high-dose and after loading bolus followed by continuous infusion of the drug in pediatric patients with leukemias.
Periclou AP; Avramis VI
Cancer Chemother Pharmacol; 1996; 39(1-2):42-50. PubMed ID: 8995498
[TBL] [Abstract][Full Text] [Related]
19. Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients.
Umamaheswaran G; Praveen RG; Damodaran SE; Das AK; Adithan C
Clin Exp Med; 2015 Nov; 15(4):511-7. PubMed ID: 25492374
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetic analysis of metformin administered as fixed-dose combination in Korean healthy adults.
Choi S; Jeon S; Han S
Transl Clin Pharmacol; 2018 Mar; 26(1):25-31. PubMed ID: 32055544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
